Diagnosis of SLE according to the EULAR/ACR criteria within three years from screening visit
Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use protected health information in accordance with national subject privacy regulations
Aged 18 to 75 years old, inclusive, at the time of informed consent
Documented diagnosis of SLE according to the current ACR criteria
Stable immunosuppressive treatment for SLE for a minimum of one year/six months
Stable treatment with antimalarials for a minimum of 3 months
stable (lasting for at least 6 months) low disease activity
You may not be if
Disease activity (non LLDAS) within 6 months prior to screening
Concomitant ongoing conditions (e.g. asthma, Crohn's disease) that require treatment with systemic GC (excluding topical or inhaled GC).
Unwillingness or inability to comply with the requirements of this protocol, including the presence of any condition (physical, mental, social) likely to affect the subject returning for follow-up visits on schedule
Nursing mothers, pregnant women or women planning to become pregnant during the study.
Clareo Health | Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus
